Lessons learned from 150 total gastrectomies for prevention of cancer.

Autor: Gallanis AF; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Bowden C; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Lopez R; Clinical Center Nutrition Department, National Institutes of Health, Bethesda, MD, United States., Gamble LA; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Samaranayake SG; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Payne C; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Snyder D; Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States., Fasaye GA; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Joyce S; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Broesamle R; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Miao N; Department of Perioperative Medicine, National Institutes of Health, Bethesda, MD, United States., Miettinen M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Quezado M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Kim SA; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Korman L; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Bethesda, MD, United States., Heller T; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Bethesda, MD, United States., Blakely AM; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Hernandez JM; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Davis JL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States. Electronic address: Jeremy.Davis@nih.gov.

Publikováno v: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2024 Nov 13, pp. 101889. Date of Electronic Publication: 2024 Nov 13.

Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.

Autor: Gallanis AF; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gamble LA; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Samaranayake SG; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Lopez R; Clinical Center Nutrition Department, National Institutes of Health, Bethesda, MD., Rhodes A; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Rajasimhan S; Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, MD., Fasaye GA; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Juma O; ASRC Federal, Bethesda, MD., Connolly M; Clincal Center Nursing Department, National Institutes of Health, Bethesda, MD., Joyce S; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Berger A; Pain and Palliative Care Service, Clinical Center, National Institutes of Health, Bethesda, MD., Heller T; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Blakely AM; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hernandez JM; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Davis JL; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Feb 01; Vol. 42 (4), pp. 421-430. Date of Electronic Publication: 2023 Oct 30.

Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.

Autor: Green BL; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Gamble LA; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Diggs LP; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Nousome D; Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, NCI, NIH, Frederick, Maryland., Patterson JC; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Joughin BA; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Gasmi B; Surgery Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lux SC; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Samaranayake SG; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Miettinen M; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland., Quezado M; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland., Hernandez JM; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yaffe MB; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Davis JL; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

Publikováno v: Molecular cancer research : MCR [Mol Cancer Res] 2023 Dec 01; Vol. 21 (12), pp. 1356-1365.

Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics.

Autor: Gamble LA; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McClelland PH; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Teke ME; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Samaranayake SG; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Juneau P; Division of Library Services, Office of Research Services, National Institutes of Health, Bethesda, MD, USA., Famiglietti AL; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Blakely AM; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Redd B; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, USA., Davis JL; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. jeremy.davis@nih.gov.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2023 Sep 27; Vol. 9 (1), pp. 77. Date of Electronic Publication: 2023 Sep 27.

Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.

Autor: Asif B; National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sarvestani AL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gamble LA; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Samaranayake SG; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Famiglietti AL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fasaye GA; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Quezado M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Miettinen M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Korman L; National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Koh C; National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Heller T; National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Davis JL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: jeremy.davis@nih.gov.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Apr; Vol. 24 (4), pp. 383-391.